Joshua Sharfstein, the Obama administration’s nominee for the No. 2 job at the FDA, will become acting chief of the agency on Monday, according to media reports. Here’s a news alert from InsideHealthPolicy.com “Joshua Sharfstein, selected by the White House for the No. 2 job at FDA, will take over Monday as acting commissioner. […]
The benefits of early anti-HIV therapy for patients with an opportunistic infection outweigh the risks, according to new guidelines from the CDC. The guidelines, developed with the NIH and the Infectious Diseases Society of America, say that for most such infections, early antiretroviral therapy will lead to better outcomes. One exception, however, is tuberculosis. […]
Some of the greatest minds on TB gathered this week here in Rio de Janeiro, Brazil, where advocates, researchers, and donors from all over the world attended the Stop TB Partnership. TB is killing nearly 2 million people a year, yet still gets far too little attention, and the purpose of the conference was to […]
HIV
Innovative approaches can help find vulnerable young women in need of HIV prevention services The following is a guest post by Michelle Li, MS, and Quinn […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
With 2018 data showing highest incidence acute flaccid myelitis since monitoring began, officials say awareness, recognition of rare life threatening condition will be crucial to early […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]